Tech Company Financing Transactions

Kalidex Pharmaceuticals Funding Round

Kalidex Pharmaceuticals closed a $6.5 million funding round on 3/31/2012. Backers included Canaan Partners, Domain Associates and Frazier Healthcare Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

70 Willow Road 200
Menlo Park, CA 94025
USA

Phone

650-325-5156

Website

www.kalidex.com

Email Address

Not Recorded

Overview

Kalidex Pharmaceuticals, Inc is a privately held anti-infective company creating the next generation of quinolones to help address the global problem of emerging infections caused by MDR organisms.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Yigong Ge

        

Browse more venture capital transactions:

Prev: 3/31/2012: Blueprint Medicines venture capital transaction
Next: 3/31/2012: Sesen Bio venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary